AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

AZN.UK

10,766

+0.71%↑

GSK

1,511

-0.07%↓

INDV

1,012

+2.12%↑

Search

Oxford Biomedica PLC

Geschlossen

334 -0.6

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

332

Max

342.5

Schlüsselkennzahlen

By Trading Economics

Einkommen

22M

-11M

Verkäufe

27M

78M

Gewinnspanne

-13.726

Angestellte

850

EBITDA

25M

5M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+87.57% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

40M

348M

Vorheriger Eröffnungskurs

334.6

Vorheriger Schlusskurs

334

Oxford Biomedica PLC Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Juni 2025, 20:45 UTC

Ergebnisse

Broadcom 2Q Sales Climb on Booming AI Demand

5. Juni 2025, 23:45 UTC

Market Talk

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5. Juni 2025, 23:44 UTC

Market Talk

Gold Edges Higher on Weak U.S. Data -- Market Talk

5. Juni 2025, 23:30 UTC

Market Talk

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5. Juni 2025, 21:32 UTC

Ergebnisse

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. Juni 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. Juni 2025, 20:45 UTC

Ergebnisse

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. Juni 2025, 20:24 UTC

Ergebnisse

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Rev $15B >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Net $4.97B >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q Adj EPS $1.58 >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom 2Q EPS $1.03 >AVGO

5. Juni 2025, 20:15 UTC

Ergebnisse

Broadcom Sees 3Q Rev $15.8B >AVGO

5. Juni 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5. Juni 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5. Juni 2025, 20:11 UTC

Akquisitionen, Fusionen, Übernahmen

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5. Juni 2025, 19:22 UTC

Market Talk

Oil Futures Resume Upward Moves -- Market Talk

5. Juni 2025, 19:00 UTC

Market Talk

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5. Juni 2025, 18:32 UTC

Market Talk

Gold Slips After Trump-Xi Call -- Market Talk

5. Juni 2025, 18:26 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5. Juni 2025, 18:06 UTC

Market Talk

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5. Juni 2025, 16:30 UTC

Akquisitionen, Fusionen, Übernahmen

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5. Juni 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

5. Juni 2025, 16:18 UTC

Market Talk

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5. Juni 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

5. Juni 2025, 16:12 UTC

Market Talk

Global Energy Roundup: Market Talk

5. Juni 2025, 16:12 UTC

Market Talk

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5. Juni 2025, 16:03 UTC

Market Talk

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5. Juni 2025, 15:49 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Oxford Biomedica PLC Prognose

Kursziel

By TipRanks

87.57% Vorteil

12-Monats-Prognose

Durchschnitt 649.002 GBX  87.57%

Hoch 798.369 GBX

Tief 498.981 GBX

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Oxford Biomedica PLC – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

2

Buy

0

Halten

0

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Oxford Biomedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.